Prokidney (PROK) Interest & Investment Income (2021 - 2026)
Prokidney's (PROK) quarterly Interest & Investment Income came in at $1.9 million in Q2 2026, down 46.06% year-over-year from $3.6 million in Q2 2025, and down 16.72% quarter-over-quarter from $2.3 million in Q1 2026.
Analysis
Prokidney (PROK) Interest & Investment Income (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Interest & Investment Income for 6 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 46.06% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $10.5 million, a 41.87% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 30.07% from the prior year.
- Interest & Investment Income was $1.9 million for Q2 2026 at Prokidney, down from $2.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $6.0 million in Q2 2023 and troughed at $1.6 million in Q3 2022.
- A 5-year average of $4.1 million and a median of $4.5 million in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 52783.23% in 2022 and slumped 46.06% in 2026, its largest moves.
- Over 5 years, Interest & Investment Income stood at $4.4 million in 2022, then gained by 19.95% to $5.3 million in 2023, then fell by 9.24% to $4.8 million in 2024, then sank by 38.75% to $2.9 million in 2025, then slumped by 33.97% to $1.9 million in 2026.
- The last three Interest & Investment Income figures came in at $1.9 million (Q2 2026), $2.3 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 7.66 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -2.69 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 3.22 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 5.60 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 5.05 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 7.49 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 366,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1.95 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 5.54 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Dec 31, 2021 | 8,324.00 |
| Sep 30, 2021 | 3,042.00 |